World's Best Scientists 2026 revealed!
Award Badge
Medicine
UK
2026

D-Index & Metrics

Medicine

D-Index
159
Citations
126598
World Ranking
802
National Ranking
84

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award

Overview

Ian O. Ellis is affiliated with the University of Nottingham in the United Kingdom. The scientist's research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular focus on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine, and Pulmonary and Respiratory Medicine.

The main topics covered in their research include:

  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • Breast Lesions and Carcinomas
  • Cancer Genomics and Diagnostics
  • Advanced Breast Cancer Therapies
  • Epigenetics and DNA Methylation
  • AI in cancer detection

Frequent publication venues for Ian O. Ellis include:

  • Histopathology
  • Breast Cancer Research and Treatment
  • Cancers
  • Cancer Research
  • Modern Pathology

Among recent notable papers are:

  • The 2019 World Health Organization classification of tumours of the breast, 2020, Histopathology
  • The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer, 2021, Nature Medicine
  • Breast tumor microenvironment structures are associated with genomic features and clinical outcome, 2022, Nature Genetics
  • Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial, 2020, The Lancet Oncology
  • Toward a fine-scale population health monitoring system, 2021, Cell

Ian O. Ellis has collaborated frequently with several researchers, including:

  • Emad A. Rakha
  • Andrew R. Green
  • Elena Provenzano
  • Cecily Quinn
  • Andrew H.S. Lee

Best Publications

  • Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

    C.W. Elston;I.O. Ellis

  • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

    Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

    Antonio C Wolff;M Elizabeth Hale Hammond;Kimberly H Allison;Brittany E Harvey

  • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

    Antonio C. Wolff;M. Elizabeth Hale Hammond;Kimberly H. Allison;Brittany E. Harvey

  • Pathological prognostic factors in breast cancer.

    Christopher W. Elston;Ian O. Ellis;Sarah E. Pinder

  • WHO classification of tumours of the breast

    Sunil R. Lakhani;Ian O. Ellis;Stuart J. Schnitt;Puay Hoon Tan

  • Prognostic markers in triple-negative breast cancer

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;Andrew H. S. Lee

  • Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

    Sahar M.A. Mahmoud;Emma Claire Paish;Desmond G. Powe;R. Douglas Macmillan

  • The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

    Bernard Pereira;Suet Feung Chin;Oscar M. Rueda;Hans Kristian Moen Vollan

  • The Nottingham Prognostic Index in primary breast cancer.

    Marcus H. Galea;Roger W. Blamey;Christopher E. Elston;Ian O. Ellis

  • Basal-Like Breast Cancer: A Critical Review

    Emad A. Rakha;Jorge S. Reis-Filho;Ian O. Ellis

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

    Cherie Blenkiron;Leonard D Goldstein;Natalie P Thorne;Inmaculada Spiteri

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

    Jack Cuzick;Mitch Dowsett;Silvia Pineda;Christopher Wale

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients

    Hamid Ali;E Provenzano;S-J Dawson;FM Blows

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    Dalia M. Abd El-Rehim;Graham Ball;Sarah E. Pinder;Emad Rakha

  • Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma

    Emad A. Rakha;Maysa E. El-Sayed;Andrew H. S. Lee;Christopher W. Elston

  • Expression of luminal and basal cytokeratins in human breast carcinoma

    Dalia M Abd El-Rehim;Sarah E Pinder;Claire E Paish;J Bell

Frequent Co-Authors

Emad A. Rakha
Emad A. Rakha University of Nottingham
Andrew R. Green
Andrew R. Green University of Nottingham
Sarah E Pinder
Sarah E Pinder King's College London
C.W. Elston
C.W. Elston University of Nottingham
Roger W. Blamey
Roger W. Blamey Nottingham City Hospital
Andrew Evans
Andrew Evans University of Dundee
John F.R. Robertson
John F.R. Robertson University of Nottingham
Carlos Caldas
Carlos Caldas University of Cambridge
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Robert Ian Nicholson
Robert Ian Nicholson Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medical careers in the USA, a wide range of online degrees can complement or provide alternatives to a traditional MD program. For those interested in fast-tracking their career in healthcare leadership, an accelerated healthcare administration degree offers a flexible route to management roles in hospitals or clinics.

Nurses seeking advanced practice can benefit from adn to msn bridge programs, which allow RNs with an associate degree to earn a master’s in nursing more quickly and conveniently online.

For those passionate about nutrition and preventive healthcare, earning your online dietitian degree can prepare you for roles in public health, wellness, or clinical settings.

Aspiring healthcare administrators looking for accredited programs should consider cahme-accredited online MHA degrees, which signal high-quality education and can lead to leadership roles in healthcare systems.

These diverse study options help students create personalized career pathways in the healthcare field, often with the advantage of flexible online learning.

Best Scientists Citing Ian O. Ellis

Trending Scientists

Recently Published Articles